2 completed, 1 not yet recruiting, 1 terminated. 4 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 2, Not yet recruiting 1, Terminated 1 |
| Phase 2 | 3 | Completed 1, Not yet recruiting 1, Terminated 1 |
Follow Dantrolene: new trials by email Literature Review of Dantrolene trials Research Report on Dantrolene
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dantrolene in Statin-induced Myopathy Dantrolene, Placebo - Statins Induced Myopathy | Phase 2 / Phase 3 | Not yet recruiting | Tanta University | 23 | 2027-10-01 | 2025-05-13 |
| A Clinical Trial Utilizing Dantrolene in Patients With Ventricular Arrhythmias. Dantrolene/Ryanodex, Placebo - Ventricular Tachycardia | Phase 2 / Phase 3 | Completed | Vanderbilt University Medical Center | 68 | 2020-08-21 | 2026-10-08 |
| Study to Assess the Efficacy and Safety of Ryanodex as Adjuvant Treatment in Subjects With EHS Ryanodex and Standard of Care, Standard of Care - Exertional Heat Stroke | Phase 3 | Completed | Eagle Pharmaceuticals, Inc. | 17 | 2018-08-19 | 2021-05-19 |
| Dantrolene for Treatment of Hyperthermia in Subarachnoidal Hemorrhage (SAH) Dantrolene, Placebo - Hyperthermia | Phase 2 / Phase 3 | Terminated | Medical University of Vienna | 34 | 2008-05-01 | 2011-05-12 |
Hyperthermia (1) · Tachycardia, Ventricular (1)
Eagle Pharmaceuticals, Inc. (1) · Medical University of Vienna (1) · Tanta University (1) · Vanderbilt University Medical Center (1)
Austria (1) · Saudi Arabia (1) · United States (1)
Adrian Hepner (1) · Andrea Holzer, MD (1) · William Stevenson, MD (1)